Immunoprecipitation of human immunodeficiency virus type 2 glycoproteins by sera positive for human immunodeficiency virus type 1.
AUTOR(ES)
Espejo, R T
RESUMO
Analysis by radioimmunoprecipitation of serum samples from 27 different human immunodeficiency virus type 1 (HIV-1)-infected individuals residing in Chile showed that the sera of 26% of these individuals also react with glycoprotein gp125 of HIV type 2 (HIV-2). This cross-reaction seems to reflect a qualitative difference among infected individuals, because the titer of antibodies against gp120 of HIV-1 in the cross-reacting samples did not differ significantly from that in the non-cross-reacting samples. Most of the HIV-1-seropositive sera, including many that did not react with gp125 of HIV-2, reacted with gp140, the precursor of HIV-2 glycoproteins. The observed cross-reactions allowed us to distinguish three groups of HIV-1-infected individuals: (i) those whose sera react with both gp140 and gp125, (ii) those whose sera react with gp140, and (iii) those whose sera react with neither of these glycoproteins. The possible cause and significance of these differences is under study.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=268113Documentos Relacionados
- Antifusion activity in sera from persons infected with human immunodeficiency virus type 1.
- Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
- Activation of the human immunodeficiency virus by herpes simplex virus type 1.
- Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
- The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.
